Latanoprost–netarsudil eye drops

Clinical Indication

Primary open-angle glaucoma or ocular hypertension

Comments

TA1009

Date of classification

November 2024

Green

Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.